Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!).

Autor: van der Arend BWH; Department of Neurology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands.; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., van Casteren DS; Department of Neurology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands., Verhagen IE; Department of Neurology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands.; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., MaassenVanDenBrink A; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Terwindt GM; Department of Neurology, Leiden University Medical Center, PO Box 9600, Leiden, 2300 RC, The Netherlands. g.m.terwindt@lumc.nl.

Publikováno v: Trials [Trials] 2024 Feb 15; Vol. 25 (1), pp. 123. Date of Electronic Publication: 2024 Feb 15.

Both perimenstrual and nonperimenstrual migraine days respond to anti-calcitonin gene-related peptide (receptor) antibodies.

Autor: Verhagen IE; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Division of Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., de Vries Lentsch S; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., van der Arend BWH; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Division of Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., le Cessie S; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands., MaassenVanDenBrink A; Division of Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: European journal of neurology [Eur J Neurol] 2023 Jul; Vol. 30 (7), pp. 2117-2121. Date of Electronic Publication: 2023 Apr 06.

Defining migraine days, based on longitudinal E-diary data.

Autor: van der Arend BWH; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Verhagen IE; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., van Leeuwen M; Leiden Institute of Advanced Computer Science, Leiden University, Leiden, The Netherlands., van der Arend MQTP; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., van Casteren DS; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Cephalalgia : an international journal of headache [Cephalalgia] 2023 May; Vol. 43 (5), pp. 3331024231166625.

Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies.

Autor: de Boer I; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands., Verhagen IE; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands., Souza MNP; Department of Neurology, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil., Ashina M; Department of Neurology, Rigshospitalet Glostrup, University of Copenhagen, Glostrup, Denmark.

Publikováno v: Cephalalgia : an international journal of headache [Cephalalgia] 2023 Feb; Vol. 43 (2), pp. 3331024221143773.

Treatment with the monoclonal calcitonin gene-related peptide receptor antibody erenumab: A real-life study.

Autor: de Vries Lentsch S; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Verhagen IE; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., van den Hoek TC; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., MaassenVanDenBrink A; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: European journal of neurology [Eur J Neurol] 2021 Dec; Vol. 28 (12), pp. 4194-4203. Date of Electronic Publication: 2021 Sep 07.